Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_404cebc72a975210ff5dbb94c743c11d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2018-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21725d4a994b90c95ff7c1d98dd16b52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0f55f197bfc573d01802ef2ea32353e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_267d3442d7d7b8b51a112645b617432a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dbe3b031eb13a8773d2ea2b0d5b34db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3ea5524cdfcf4ea65a23e264abc9784 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b4c42a07d726a9ce5f4be1ed98c6382 |
publicationDate |
2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018142363-A1 |
titleOfInvention |
Ready to use compositions of glp-2 analogues through self-administrable devices |
abstract |
The present invention relates to a stable ready-to-use pharmaceutical preparation of GLP-2 analogue for parenteral administration, wherein the preparation comprises GLP-2 analogue or its pharmaceutically acceptable salt thereof and pharmaceutically acceptable excipients; further the composition comprises of multi dose fixed dose and/ or single dose injections through self- administrable devices. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279702-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3628682-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020065063-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11407768-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512065-B2 |
priorityDate |
2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |